The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis

Table 2

Demographical and clinical characteristics of patients with UC.

Clinical characteristics of UC patients			%	TRPV1 expression median (range)
Gender	Male	17	50	10.53 (7.86–18.57)	0.94
	Female	17	50	10.73 (7.82–17.57)
Age at diagnosis	<40	25	73.52	10.90 (7.82–13.29)	0.02
	>40	8	23.52	9.82 (8.18–11.37)
Extraintestinal manifestations	Present	33	62.3	10.33 (7.83–18.57)	0.18
	Absent	20	37.7	10.93 (7.82–13.29)
Extent of disease	Left colitis (E2) and distal colitis (E1)	15	45.5	10.73 (8.47–1.39)	0.91
	Extensive colitis (E3)	18	54.5	10.65 (7.82–13.29)
Years of evolution	<3	18	54.5	10.65 (8.47–13.29)	1.00
	>3	15	45.5	10.90 (7.82–12.39)
Clinical course of disease	Nonrelapsing disease	14	42.4	10.33 (7.82–13.29)	0.07
	Relapsing disease	19	57.6	10.90 (8.18–12.74)

Extent of disease is presented according to Montreal classification for disease extent in patients with ulcerative colitis (Satsangi J. 2006).